EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways

Li-Shan Yan, Shuang Cui, Brian Chi-Yan Cheng iD, Xing-Bin Yin, Yi-Wei Wang, Xin-Yu Qiu, Ci-Ren Nima, Yi Zhang iD, Shuo-Feng Zhang

Drug Design, Development and Therapy · 2023

DOI: 10.2147/dddt.s372981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Li-Shan Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Acute Lung Injury, Toll-Like Receptor 4. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryToll-Like Receptor 4AnimalsMiceAnti-Inflammatory AgentsChemokine CCL3Interleukin-6LipopolysaccharidesNF-kappa BSignal TransductionTumor Necrosis Factor-alphaMedicine, Tibetan Traditional

Stichwörter der Autor:innen

RAW264.7 macrophagesSichen formulaTLR4 signaling pathwaysacute lung injurylipopolysaccharide

Substanzen

Anti-Inflammatory AgentsChemokine CCL3Interleukin-6LipopolysaccharidesNF-kappa BTlr4 protein, mouseToll-Like Receptor 4Tumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, People's Republic of China.
  • College of Professional and Continuing Education, Hong Kong Polytechnic University, Hong Kong, People's Republic of China.
  • Tibetan Traditional Medical College, Lhasa, Tibet, People's Republic of China.

ORCID-Profile: Brian Chi-Yan Cheng, Yi Zhang

Zitieren

APA

Yan, L. S., Cui, S., Cheng, B. C., Yin, X. B., Wang, Y. W., Qiu, X. Y., Nima, C. R., Zhang, Y., & Zhang, S. F. (2023). Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s372981

Vancouver

Yan LS, Cui S, Cheng BC, Yin XB, Wang YW, Qiu XY, et al. Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s372981

BibTeX
@article{Yan2023,
  author = {Yan, Li-Shan and Cui, Shuang and Cheng, Brian Chi-Yan and Yin, Xing-Bin and Wang, Yi-Wei and Qiu, Xin-Yu and Nima, Ci-Ren and Zhang, Yi and Zhang, Shuo-Feng},
  title = {Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways},
  journal = {Drug Design, Development and Therapy},
  year = {2023},
  doi = {10.2147/dddt.s372981}
}
Kostenlos starten →